SCHEMBL27141933

SCHEMBL27141933

Cn1cc(S(=O)(=O)Nc2cccc3cnn(C)c23)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 1/20 0.45
▸ SLC40A1 Q9NP59 8/20 0.41
▸ CCR4 P51679 2/20 0.38
▸ GLO1 Q04760 4/20 0.38
▸ AGTR1 P30556 3/20 0.38
▸ EGFR P00533 3/20 0.38
▸ FGFR1 P11362 3/20 0.38
▸ KDR P35968 3/20 0.38
▸ PAX8 Q06710 2/20 0.38
▸ CYBB P04839 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ TDP1 Q9NUW8 3/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MITF O75030 1/20 0.37
▸ S1PR4 O95977 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ S1PR1 P21453 1/20 0.37
▸ OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30846492 0.83 PIK3CD (0.39) PTPN11SLC40A1CCR4GLO1AGTR1
SCHEMBL27117954 0.83 PIK3CD (0.39) PTPN11SLC40A1CCR4GLO1AGTR1
SCHEMBL27133418 0.81 SLC40A1 (0.43) PTPN11SLC40A1GLO1AGTR1PAX8
SCHEMBL27143257 0.80 PTPN11 (0.39) PTPN11SLC40A1CCR4GLO1AGTR1
SCHEMBL27138912 0.80 ACLY (0.43) PTPN11SLC40A1CCR4GLO1AGTR1
SCHEMBL30847917 0.79 SLC40A1 (0.41) PTPN11SLC40A1GLO1AGTR1PAX8
SCHEMBL27132412 0.79 SLC40A1 (0.41) PTPN11SLC40A1GLO1AGTR1PAX8
SCHEMBL27154324 0.79 HTR6 (0.38) PTPN11SLC40A1EGFRTDP1ALDH1A1
SCHEMBL30846193 0.79 GAA (0.55) PTPN11SLC40A1CCR4GLO1AGTR1
SCHEMBL27123592 0.79 GAA (0.55) PTPN11SLC40A1CCR4GLO1AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback